Trial Profile
Clinical Trials Insight: 700048709
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 12 Sep 2009
Price :
$35
*
At a glance
- Drugs HF 0220 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Newron Pharmaceuticals